Chiranjoy Mukhopadhyay Ankita Garg Archana Ayyagari
10.1186/1471-2334-4-63
BMC Infect Dis
2004 Dec 23;4(1):63.
CC BY
https://pubmed.ncbi.nlm.nih.gov/15617569/
Antitubercular Agents / pharmacology Immunocompromised Host / drug effects Immunosuppressive Agents / adverse effects Mycobacterium tuberculosis / drug effects Polymyositis / complications Tuberculosis, Miliary / complications
Antitubercular Agents / pharmacology Immunocompromised Host / drug effects Immunosuppressive Agents / adverse effects Mycobacterium tuberculosis / drug effects Polymyositis / complications Tuberculosis, Miliary / complications Case Reports Abscess / drug therapy Abscess / microbiology Adult Antitubercular Agents / administration & dosage Bacterial Proteins / genetics DNA Primers / chemistry Drug Resistance, Multiple, Bacterial / drug effects Humans Immunosuppressive Agents / therapeutic use Male Microbial Sensitivity Tests / methods Mycobacterium tuberculosis / classification Mycobacterium tuberculosis / genetics Mycobacterium tuberculosis / isolation & purification Polymerase Chain Reaction / methods Polymorphism, Restriction Fragment Length Polymyositis / drug therapy Polymyositis / immunology Recurrence Skin Diseases, Bacterial / drug therapy Skin Diseases, Bacterial / microbiology Transcription Factors / genetics Treatment Outcome Tuberculosis, Miliary / drug therapy Antitubercular Agents Bacterial Proteins DNA Primers DevR protein, Nostoc Immunosuppressive Agents Transcription Factors
PMC548298
15617569
First documented cure of a suggestive exogenous reinfection in polymyositis with same but multidrug resistant M. tuberculosis
2004